Skip to main content
Erschienen in: Journal of General Internal Medicine 7/2010

01.07.2010 | Original Article

What Is Most Important to Patients when Deciding about Colorectal Screening?

verfasst von: Avlin Imaeda, MD, PhD, Danielle Bender, MD, Liana Fraenkel, MD, MPH

Erschienen in: Journal of General Internal Medicine | Ausgabe 7/2010

Einloggen, um Zugang zu erhalten

Abstract

BACKGROUND

Colorectal cancer (CRC) screening can be administered through tests with varied characteristics and is a preference-sensitive decision.

OBJECTIVE

To assess patient experiences with a Maximum Differences Scaling (MDS) tool for eliciting values about CRC screening test characteristics and determine whether patients vary in how they prioritize test characteristics and whether this variation relates to test preferences.

DESIGN

MDS survey to elicit patients’ values for characteristics related to fecal occult blood testing, sigmoidoscopy, colonoscopy, CT colonography and colon capsule endoscopy.

PARTICIPANTS

92 patients enrolled in primary care clinics at a VA hospital and associated university.

RESULTS

Patients reported that the tool was easy to use (95%). On completion 62% would choose colonoscopy, 23% colon capsule endoscopy and 10% CT colonography. Of the attributes evaluated, patients valued sensitivity, risk of tear and need for a second test most. Sensitivity was more important to those choosing colonoscopy than those choosing other tests (median importance = 21.5 versus 19.6, p < 0.01). Concern with complications and sedation was positively associated with age (p < 0.001 and p < 0.001), whereas concern with colon preparation and missing work was negatively associated with age (p < 0.009 and p < 0.03). Patients with fair or poor health status were less concerned with sensitivity than patients in good to excellent health (median importance = 19.3 versus 21.4, p < 0.008).

CONCLUSIONS

This pilot study suggests that patients vary in how they prioritize colorectal cancer screening test attributes; this variation is associated with test preferences, and this MDS tool is feasible to use and may help patients construct their preferences.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Beauchamp T, Childress J. Principles of Biomedical Ethics. New York: Oxford University Press; 1983. Beauchamp T, Childress J. Principles of Biomedical Ethics. New York: Oxford University Press; 1983.
2.
Zurück zum Zitat Allicock M, Sandelowski M, DeVellis B, Campbell M. Variations in meanings of the personal core value "Health". Patient Educ Counsel. 2008;73:347–53.CrossRef Allicock M, Sandelowski M, DeVellis B, Campbell M. Variations in meanings of the personal core value "Health". Patient Educ Counsel. 2008;73:347–53.CrossRef
3.
Zurück zum Zitat Reyna V. A theory of medical decision making and health: fuzzy trace theory. Med Decis Making. 2008;28:850–65.CrossRefPubMed Reyna V. A theory of medical decision making and health: fuzzy trace theory. Med Decis Making. 2008;28:850–65.CrossRefPubMed
4.
Zurück zum Zitat Mandel J, Bond J, Church T, for the Minnesota colon cancer control study, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365–71.CrossRefPubMed Mandel J, Bond J, Church T, for the Minnesota colon cancer control study, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365–71.CrossRefPubMed
5.
Zurück zum Zitat Kronborg O, Fenger C, Olsen J, Jorgensen O, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–71.CrossRefPubMed Kronborg O, Fenger C, Olsen J, Jorgensen O, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–71.CrossRefPubMed
6.
Zurück zum Zitat Hardcastle J, Chamberlain J, Robinson M, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–7.CrossRefPubMed Hardcastle J, Chamberlain J, Robinson M, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–7.CrossRefPubMed
7.
Zurück zum Zitat Winawer S, Zauber A, Ho M, The National Polyp Study Group, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977–81.CrossRefPubMed Winawer S, Zauber A, Ho M, The National Polyp Study Group, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977–81.CrossRefPubMed
8.
Zurück zum Zitat Newcomb P, Norfleet R, Storer B, Surawicz T, Marcus P. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572–5.CrossRefPubMed Newcomb P, Norfleet R, Storer B, Surawicz T, Marcus P. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572–5.CrossRefPubMed
9.
Zurück zum Zitat Muller A, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. Arch Intern Med. 1995;155:1741–48.CrossRefPubMed Muller A, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. Arch Intern Med. 1995;155:1741–48.CrossRefPubMed
10.
Zurück zum Zitat Selby J, Friedman G, Quesenberry C, Weiss N. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653–7.PubMedCrossRef Selby J, Friedman G, Quesenberry C, Weiss N. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653–7.PubMedCrossRef
12.
13.
Zurück zum Zitat Eliakim R, Fireman Z, Gralnek I, et al. Evaluation of the PillCam™ Colon capsule in the detection of colonic pathology: results of the first multicenter, prospective, comparative study. Endoscopy. 2006;38:963–70.CrossRefPubMed Eliakim R, Fireman Z, Gralnek I, et al. Evaluation of the PillCam™ Colon capsule in the detection of colonic pathology: results of the first multicenter, prospective, comparative study. Endoscopy. 2006;38:963–70.CrossRefPubMed
14.
Zurück zum Zitat Schoofs N, Deviere J, Van Gossun A. PillCam™ colon capsule endoscopy compared with colonoscopy for colorectal tumor diagnosis: a prospective pilot study. Endoscopy. 2006;38:971–7.CrossRefPubMed Schoofs N, Deviere J, Van Gossun A. PillCam™ colon capsule endoscopy compared with colonoscopy for colorectal tumor diagnosis: a prospective pilot study. Endoscopy. 2006;38:971–7.CrossRefPubMed
15.
Zurück zum Zitat Pignone M, Bucholtz D, Harris R. Patient preferences for colon cancer screening. J Gen Intern Med. 1999;14:432–7.CrossRefPubMed Pignone M, Bucholtz D, Harris R. Patient preferences for colon cancer screening. J Gen Intern Med. 1999;14:432–7.CrossRefPubMed
16.
Zurück zum Zitat Pignone M. Patient preferences for colon cancer screening: the role of out-of-pocket costs. Am J Managed Care. 2007;13:390–92. Pignone M. Patient preferences for colon cancer screening: the role of out-of-pocket costs. Am J Managed Care. 2007;13:390–92.
17.
Zurück zum Zitat Schroy P, Lal S, Glick J, Robinson P, Zamor P, Heerem T. Patient preferences for colorectal cancer screening: how does stool DNA testing fare? Am J Managed Care. 2007;13:393–400. Schroy P, Lal S, Glick J, Robinson P, Zamor P, Heerem T. Patient preferences for colorectal cancer screening: how does stool DNA testing fare? Am J Managed Care. 2007;13:393–400.
18.
Zurück zum Zitat Pignone M, Harris R, Kinsinger L. Videotape-based decision aid for colon cancer screening. A randomized, controlled trial. Ann Intern Med. 2000;133:761–69.PubMed Pignone M, Harris R, Kinsinger L. Videotape-based decision aid for colon cancer screening. A randomized, controlled trial. Ann Intern Med. 2000;133:761–69.PubMed
19.
Zurück zum Zitat Dolan N, Frisina S. Randomized controlled trial of a patient decision aid for colorectal cancer screening. Med Decis Making. 2002;22:125–39.PubMed Dolan N, Frisina S. Randomized controlled trial of a patient decision aid for colorectal cancer screening. Med Decis Making. 2002;22:125–39.PubMed
20.
Zurück zum Zitat Griffith J, Lewis C, Brenner A, Pignone M. The effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial. BMC Med Inform and Decis Making. 2008;8:4–9.CrossRef Griffith J, Lewis C, Brenner A, Pignone M. The effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial. BMC Med Inform and Decis Making. 2008;8:4–9.CrossRef
21.
Zurück zum Zitat Griffith J, Fichter M, Fowler F, Lewis C, Pignone M. Should a colon cancer screening decision aid include the option of no testing? A comparative trial of two decision aids. BMC Med Inform and Decis Making. 2008;8:10–9.CrossRef Griffith J, Fichter M, Fowler F, Lewis C, Pignone M. Should a colon cancer screening decision aid include the option of no testing? A comparative trial of two decision aids. BMC Med Inform and Decis Making. 2008;8:10–9.CrossRef
22.
Zurück zum Zitat Kim J, Whitney A, Hayter S, et al. Development and initial testing of a computer-based patient decision aid to promote colorectal cancer screening for primary care practice. BMC Med Inform and Decis Making. 2005;5:36–47.CrossRef Kim J, Whitney A, Hayter S, et al. Development and initial testing of a computer-based patient decision aid to promote colorectal cancer screening for primary care practice. BMC Med Inform and Decis Making. 2005;5:36–47.CrossRef
23.
Zurück zum Zitat Ruffin M, Fetters P, Jimbo M. Preference-based electronic decision aid to promote colorectal cancer screening: Results of a randomized controlled trial. Prevent Med. 2007;45:267–73.CrossRef Ruffin M, Fetters P, Jimbo M. Preference-based electronic decision aid to promote colorectal cancer screening: Results of a randomized controlled trial. Prevent Med. 2007;45:267–73.CrossRef
24.
Zurück zum Zitat Van Dam L, Hol L, Bekker-Grob E, et al. What determines individuals’ preferences for colorectal cancer screening programmes? A discrete choice experiment. Eur J Cancer 2009;(2009). doi:10.1016/j.ejca.2009.07.014. Van Dam L, Hol L, Bekker-Grob E, et al. What determines individuals’ preferences for colorectal cancer screening programmes? A discrete choice experiment. Eur J Cancer 2009;(2009). doi:10.​1016/​j.​ejca.​2009.​07.​014.
25.
Zurück zum Zitat Hawley S, Volk R, Krishnamurthy P, Jibaja-Weiss M, Vernon S, Kneuper S. Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Med Care. 2008;46:S10–6.CrossRefPubMed Hawley S, Volk R, Krishnamurthy P, Jibaja-Weiss M, Vernon S, Kneuper S. Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Med Care. 2008;46:S10–6.CrossRefPubMed
26.
Zurück zum Zitat Marshall D, Johnson F, Phillips K, Marshall J, Thabane L, Kulin N. Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health. 2007;10:415–30.CrossRefPubMed Marshall D, Johnson F, Phillips K, Marshall J, Thabane L, Kulin N. Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health. 2007;10:415–30.CrossRefPubMed
27.
Zurück zum Zitat Dolan J. Patient priorities in colorectal cancer screening decisions. Health Expect. 2005;8:334–44.CrossRefPubMed Dolan J. Patient priorities in colorectal cancer screening decisions. Health Expect. 2005;8:334–44.CrossRefPubMed
28.
Zurück zum Zitat U.S Preventative Services Task Force USPST. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:627–37. U.S Preventative Services Task Force USPST. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:627–37.
29.
Zurück zum Zitat Louviere, J. The best-worst or maximum difference measurement model: Applications to behavioral research in marketing. The American Marketing Association's Behavioral Research Conference Phoenix, Arizona 1993. Louviere, J. The best-worst or maximum difference measurement model: Applications to behavioral research in marketing. The American Marketing Association's Behavioral Research Conference Phoenix, Arizona 1993.
30.
Zurück zum Zitat Flynn T, Louviere J, Peters T, Coast J. Estimating preferences for a dermatology consultation using Best-Worst Scaling: comparison of various methods of analysis. BMC Med Res Methodol. 2008;8:76–88.CrossRefPubMed Flynn T, Louviere J, Peters T, Coast J. Estimating preferences for a dermatology consultation using Best-Worst Scaling: comparison of various methods of analysis. BMC Med Res Methodol. 2008;8:76–88.CrossRefPubMed
34.
Zurück zum Zitat Fraenkel L, Bogardus S, Concato J, Felson D, Wittink D. Patient preferences for treatment of rheumatoid arthritis. Ann Rheum Dis. 2004;63:1372–8.CrossRefPubMed Fraenkel L, Bogardus S, Concato J, Felson D, Wittink D. Patient preferences for treatment of rheumatoid arthritis. Ann Rheum Dis. 2004;63:1372–8.CrossRefPubMed
35.
Zurück zum Zitat Longacre A, Imaeda A, Garcia-Tsao G, Fraenkel L. A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage. Hepatology. 2008;47:169–76.CrossRefPubMed Longacre A, Imaeda A, Garcia-Tsao G, Fraenkel L. A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage. Hepatology. 2008;47:169–76.CrossRefPubMed
36.
Zurück zum Zitat DeBourcy A, Lichtenberger S, Felton S, Butterfield K, Ahnen D, Denberg T. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med. 2007;23:169–74.CrossRefPubMed DeBourcy A, Lichtenberger S, Felton S, Butterfield K, Ahnen D, Denberg T. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med. 2007;23:169–74.CrossRefPubMed
37.
Zurück zum Zitat Almog R, Ezra G, Lavi I, Rennert G, Hagoel L. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening. Eur J Cancer Prevent. 2008;17:430–37.CrossRef Almog R, Ezra G, Lavi I, Rennert G, Hagoel L. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening. Eur J Cancer Prevent. 2008;17:430–37.CrossRef
38.
Zurück zum Zitat Ling B, Moskowitz M, Wachs D, Pearson B, Schroy P. Attitudes toward colorectal cancer screening tests. A survey of patients and physicians. J Gen Intern Med. 2001;16:822–30.CrossRefPubMed Ling B, Moskowitz M, Wachs D, Pearson B, Schroy P. Attitudes toward colorectal cancer screening tests. A survey of patients and physicians. J Gen Intern Med. 2001;16:822–30.CrossRefPubMed
39.
Zurück zum Zitat Leard L, Savides T, Ganiats T. Patient preferences for colorectal cancer screening. J Fam Pract. 1997;45:211–18.PubMed Leard L, Savides T, Ganiats T. Patient preferences for colorectal cancer screening. J Fam Pract. 1997;45:211–18.PubMed
40.
Zurück zum Zitat Nelson R, Schwartz A. A survey of individual preference for colorectal cancer screening technique. BMC Cancer. 2004;4:76.CrossRefPubMed Nelson R, Schwartz A. A survey of individual preference for colorectal cancer screening technique. BMC Cancer. 2004;4:76.CrossRefPubMed
41.
Zurück zum Zitat Wolf R, Basch C, Brouse C, Shmuckler C, Shea S. Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health. 2006;96:809–11.CrossRefPubMed Wolf R, Basch C, Brouse C, Shmuckler C, Shea S. Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health. 2006;96:809–11.CrossRefPubMed
42.
Zurück zum Zitat Powell A, Burgess A, Vernon S, et al. Colorectal cancer screening mode preferences among US veterans. Prevent Med. 2009;49:442–48.CrossRef Powell A, Burgess A, Vernon S, et al. Colorectal cancer screening mode preferences among US veterans. Prevent Med. 2009;49:442–48.CrossRef
43.
Zurück zum Zitat McGregor E, Hilsden R, Li F, Bryant H, Murray A. Low uptake of colorectal cancer screening 3 years after release of national recommendations for screening. Am J Gastro. 2007;102:1727–35.CrossRef McGregor E, Hilsden R, Li F, Bryant H, Murray A. Low uptake of colorectal cancer screening 3 years after release of national recommendations for screening. Am J Gastro. 2007;102:1727–35.CrossRef
44.
Zurück zum Zitat Meissner H, Breen N, Klabunde C, Vernon S. Patterns of colorectal cancer screening uptake among men and woman in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15:389–94.CrossRefPubMed Meissner H, Breen N, Klabunde C, Vernon S. Patterns of colorectal cancer screening uptake among men and woman in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15:389–94.CrossRefPubMed
Metadaten
Titel
What Is Most Important to Patients when Deciding about Colorectal Screening?
verfasst von
Avlin Imaeda, MD, PhD
Danielle Bender, MD
Liana Fraenkel, MD, MPH
Publikationsdatum
01.07.2010
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 7/2010
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-010-1318-9

Weitere Artikel der Ausgabe 7/2010

Journal of General Internal Medicine 7/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.